Hemodialysis patients with hyperphosphatemia
Conditions
Interventions
1) Bixalomer: The patients managed hyperphosphatemia with taking bixalomer just before each meal will take them after each meal. The dose of bixalomer is fixed during the observation. The level of
Sponsors
Juntendo University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients are eligible if they are compatible with the following criteria. 1.hemodialysis patients complicated with hyperphosphorous who managed with bixalomer. 2.30 patients with agreement for exchange of midication mode from taking bixalomer before meal to after meal. 3.Patients who is available for the record to questionnaires (an abdominal symptom, medication situation questionnaire). 4.Patients who we agreed with the participation of the study based on informed consent before the study initiation, and filled in signature sealing or a signature and a date
Exclusion criteria
Exclusion criteria: ients are excluded if they are compatible with any one of the following criteria. 1.Patients with a history of hypersensitivity for an ingredient of this medicine 2.Patients with bowel obstruction (for a non-absorbable polymer, we might raise intestinal perforation) 3.Patients with significant psychic disturbance or drug dependence disease or alcoholism 4.Patients that going to hospital of all follow-up seems to be impossible 5.Patients who are not able to understand a test instructions from medical experts of the client side or the doctors involved in the study 6.Patients who judged as inadequate by the doctors involved in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of serum phosphate | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of efficacy *Blood gas concentrations *Abdominal symptoms evaluation *Drug remedy time estimation *Adverse events | — |
Countries
Japan
Contacts
Public ContactChieko Hamada
Juntendo University Faculty of Medicine Department of Internal Medicine, Division of Nephrology
Outcome results
None listed